GENERA BIOTECH
Generabiotech is a mediator venture between the scientific and business communities, catalyzing the transfer of biotechnology and its commercial exploitation. The company aims to generate knowledge as well as to pinpointing scientific findings with commercial potential for catalyzing their transformation into value in the market through partnerships with the academia and the business. Its service portfolio includes knowledge transfer, launching bio startups, NIH calls, European calls, and Spanish R&D certification. Genera Biotech is based in Valencia, Spain.
GENERA BIOTECH
Industry:
Biotechnology
Address:
Valencia, Comunidad Valenciana, Spain
Country:
Spain
Website Url:
http://www.generabiotech.com
Status:
Active
Contact:
34960046932
Technology used in webpage:
Energy Group Hosting DynaDot
Similar Organizations
Bilhi Genetics
Bilhi Genetics is a biotech company at the edge of biotechnology and digital technologies.
Current Employees Featured
Official Site Inspections
http://www.generabiotech.com
- Host name: ec2-54-215-31-113.us-west-1.compute.amazonaws.com
- IP address: 54.215.31.113
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Genera Biotech"
GeneraBiotec
GeneraBiotec specialises in manufacturing products for human cell therapy. Actual catalog includes bone marrow and fat mesenchymal cells, fibroblasts, condrocytes, and our exclusive …See details»
Generate:Biomedicines - Wikipedia
Generate’s research is centered on leveraging machine learning to program proteins for specific functions. [4] Its platform is trained on extensive datasets comprising 160,000 protein …See details»
What Do We Share as Generators? - Generate:Biomedicines
Mar 3, 2023 Second, we all act as owners of the organization. We share an open, inclusive, and collaborative culture based on integrity, trust, and a passion for learning. Generators are …See details»
Generate Biomedicines - Crunchbase Company Profile & Funding
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug …See details»
Genera Biotech - Crunchbase Company Profile & Funding
Generabiotech is a mediator venture that aims to catalyze the transfer of biotechnology and its commercial exploitation.See details»
Generation Bio - Crunchbase Company Profile & Funding
Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare …See details»
Generate Biomedicines Announces First External… | Flagship …
Nov 18, 2021 This financing will enable Generate Biomedicines to advance and evolve the platform as well as rapidly scale the organization with top-tier scientific and computational …See details»
Generate: Biomedicines: 2024 CNBC Disruptor 50
May 14, 2024 Generate: Biomedicines is among a new group of companies using generative AI to speed up the drug discovery process, reducing development time and cost.See details»
Generate Biomedicines | Company Overview & News - Forbes
Generate Biomedicines is setting out to “program” medicine by almost instantaneously creating models of new proteins. Launched out of life sciences venture firm Flagship Pioneering, it …See details»
Four Years of Generate: The Leading Edge of a Revolution
Sep 21, 2022 We are building an organization that goes beyond conventional business models and pushes the limits of what can be done in this space. We stand on the leading edge of a …See details»
Generate:Biomedicines Fortifies Leadership in Generative AI with ...
Jan 4, 2024 Mike Nally, Chief Executive Officer, will overview these updates, as well as share more about the company’ s strategy to further strengthen its leadership in generative biology, …See details»
Flagship-founded Generate snags $370M to generate medicines …
Nov 18, 2021 Generate Biomedicines wants to get in on the lucrative world of protein-based therapeutics, which comprise about 7 in 10 new drug approvals. The Flagship Pioneering …See details»
Generation Bio - Craft
Oct 22, 2024 Generation Bio is a genetic medicines company creating gene therapy utilizing its non-viral gene therapy platform. It combines three technologies: a cell-targeted lipid …See details»
Generation Bio to Present at American Society of Gene & Cell …
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene …See details»
Generate:Biomedicines | Generate:Biomedicines Announces Multi …
Sep 24, 2024 Somerville, Mass., September 24, 2024 – Generate:Biomedicines (“Generate”) today announced a multi-target collaboration with Novartis (NYSE: NVS) to discover and …See details»
Moderna and Generation Bio Announce Strategic Collaboration to …
Mar 23, 2023 Collaboration will extend the applications of each company's platform through discovery and development of novel lipid nanoparticles using Generation Bio's proprietary …See details»
Generation Bio - Generation Bio
Our cell-targeted lipid nanoparticle delivery system is potent and selective, engineered to reach previously unreachable tissues and cell types.See details»
Moderna and Generation Bio Announce Strategic Collaboration
Mar 24, 2023 Moderna announced on March 23, 2023 a collaboration with Generation Bio, a biotechnology company innovating genetic medicines for people living with rare and prevalent …See details»
Generation Bio Announces Update to Its GMP Manufacturing …
Jun 21, 2022 Company projects smaller GMP manufacturing footprint, enabled by further process development of rapid enzymatic synthesis of ceDNA at scale. Company will seek to …See details»
Generation Bio Announces Breakthrough in its Non-Viral Genetic …
Oct 18, 2023 – Immune-quiet DNA (iqDNA) is a novel variant of closed-ended DNA (ceDNA) that evades host innate immune detection in both mice and non-human primates (NHPs) with …See details»